| HRIOX | OSMCX | HRIOX / OSMCX | |
| Total Expense Ratio | 1.23 | 2.13 | 58% |
| Annual Report Gross Expense Ratio | 5.49 | 2.13 | 258% |
| Fund Existence | 4 years | 28 years | - |
| Gain YTD | 42.735 | 15.981 | 267% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 25000 | 1000 | 2,500% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 191M | 2.73B | 7% |
| Annual Yield % from dividends | 0.11 | 0.48 | 23% |
| Returns for 1 year | 44.69 | 0.82 | 5,428% |
| Returns for 3 years | 121.94 | 2.40 | 5,076% |
| Returns for 5 years | N/A | -27.38 | - |
| Returns for 10 years | N/A | 7.46 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SVXFX | 74.21 | 0.58 | +0.79% |
| Smead International Value I1 | |||
| WSTYX | 83.25 | 0.14 | +0.17% |
| Macquarie Science and Technology Y | |||
| AWSSX | 18.36 | N/A | N/A |
| Invesco Global Core Equity R6 | |||
| CSMIX | 45.80 | -0.01 | -0.02% |
| Columbia Small Cap Value Discv A | |||
| CLTCX | 16.37 | -0.07 | -0.43% |
| Catalyst/Lyons Tactical Allocation C | |||